ShenZhen GTJA Investment Group

Qingpai Technology is a developer of photoacoustic biomedical imaging technology. It develops new clinical medical and high-end scientific research imaging platform products based on photoacoustic imaging technology, which can be used for early screening and diagnosis of breast cancer, pre-and post-operative skin flap transplantation evaluation, preoperative parathyroid detection and positioning imaging, male genital vascular imaging, skin medical cosmetology, and carotid artery plaque detection imaging.

Rosenbot provides medical robot technology and uses technological innovation to promote the reform of medical models. It is committed to creating a new generation of orthopedic surgery robot systems with intelligent fracture reduction functions, it is the first in the world to realize advanced technologies such as intraoperative real-time 3D navigation, assisted fracture reduction operation, automatic operation planning, etc. The intelligent surgical operation of the whole operation process meets the urgent needs of clinical treatment.

TOPI Imaging Technology is a medical device firm providing OCT retinal diagnostic system and sweep optical biometer.

IMPACT Therapeutics, Inc. is a biotechnology company based in Shanghai, China, focused on discovering, developing, and commercializing innovative therapeutics for cancer and other life-threatening diseases. Founded in 2009, the company is dedicated to creating targeted anti-cancer treatments that leverage the concept of synthetic lethality. Its research and development efforts include a variety of novel drug projects, such as PARP inhibitors, Wee1 inhibitors, and agents targeting the Hedgehog pathway, among other DNA damage response (DDR) agents. Through its commitment to advancing targeted therapies, IMPACT Therapeutics aims to provide patients with new, effective treatment options for challenging medical conditions.

Kanova is a biopharmaceutical company dedicated to the development of therapeutic antibodies and innovative combination therapies targeting immuno-oncology and autoimmune diseases. The company offers a biomedical technology service platform that supports pharmaceutical research and production in biotechnology. It specializes in antibody-based drugs that enhance immune system function, along with providing technical consultation and drug quality inspection services. By focusing on these areas, Kanova aims to help clients improve drug quality and advance the discovery of new biomedicine efficiently.

Precision Scientific specializes in drug mechanism research services tailored for pharmaceutical and biotechnology firms. Utilizing its proprietary AI technology, ALBERT, the company employs advanced machine learning techniques to analyze multi-omics data. This innovative approach aids in various aspects of oncology research, including drug target discovery, biomarker identification, indication selection, evaluation of drug resistance mechanisms, and the development of combination therapy strategies. Additionally, Precision Scientific offers comprehensive contract research organization (CRO) services that encompass clinical development, biomarker and companion diagnostic development, biometrics, regulatory strategy, and commercialization support, thereby enhancing cancer care for both pharmaceutical companies and healthcare institutions.

3H Pharmaceuticals focuses on the research and development of macromolecular antibody drugs and innovative small molecules.

TenNor Therapeutics is a clinical-stage product development company focused on addressing unmet medical needs in infectious diseases. The company utilizes a dual-acting drug discovery platform to develop innovative treatments for a range of conditions, including Helicobacter pylori infections, prosthetic joint infections, and multidrug-resistant Gram-negative infections. Additionally, TenNor is engaged in creating therapies for diseases associated with bacterial infections and dysbiosis, particularly targeting gastrointestinal tract infections and medical device-related infections. Through its multi-targeting approach, TenNor aims to bring new therapeutic options to patients suffering from various serious infectious diseases.

Atom Bioscience is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory and metabolic diseases. The company concentrates on addressing conditions such as chronic gout, non-alcoholic steatohepatitis, diabetes, and colon cancers. By targeting the underlying mechanisms of metabolism and inflammation, Atom Bioscience aims to provide patients with more effective treatment options for these complex health issues.

Cloudbreak Therapeutics LLC is a clinical-stage biotechnology company based in Irvine, California, focused on developing ocular drugs for conditions such as glaucoma and pterygium. Founded in 2015, the company utilizes a capital-efficient business model that repurposes approved systemic drugs for ocular delivery. By prioritizing the rapid advancement of drug candidates through proof-of-concept Phase II clinical trials, Cloudbreak Therapeutics aims to out-license global rights for Phase III trials, product registration, and commercialization. The company strategically collaborates with contract research organizations to manage non-clinical, chemistry, manufacturing, and clinical development, thus maximizing its resources for effective drug development.

DK Medtech, founded in 2015 and headquartered in Suzhou, China, specializes in the development and production of balloon catheter medical devices. The company is recognized as a leader in the medical device industry, focusing on innovative technologies that aim to meet the evolving challenges in healthcare. Through its commitment to excellence, DK Medtech strives to create impactful solutions that enhance patient care and improve medical outcomes.

Boan Biotech is a fully integrated biopharmaceutical company specializing in the development, manufacture, and commercialization of therapeutic antibodies. The company focuses on several key therapeutic areas, including oncology, metabolism, autoimmunity, and ophthalmology. While it primarily generates revenue from customers in Mainland China, Boan Biotech aims to expand its reach globally. The company is committed to delivering high-quality biologics to address unmet medical needs in these critical fields.

VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases. VivaVision Biotech is dedicated to bringing new therapeutics to millions of patients suffering from chronic ocular or dermal inflammatory diseases.

Teligene Ltd. is a pharmaceutical research and development company based in Jiangsu, China, established in 2011. The company specializes in the development of small-molecule drugs, particularly innovative treatments for oncology. Teligene's focus is on the research, development, and industrialization of small molecule targeted anti-tumor drugs, utilizing advanced drug development technologies. The experienced management team is well-versed in contemporary trends and practices in drug development both domestically and internationally. Teligene aims to create original anti-tumor drugs with independent intellectual property rights, addressing emerging areas of research and development in the pharmaceutical field.

Lyvgen Biopharma Co. Ltd., founded in 2016 and based in Shanghai, China, specializes in the research, development, and production of immuno-oncology drug candidates. The company focuses on creating innovative antibody therapies, including its proprietary PD-1 antibody SSI-361, which aims to activate specific receptors within the tumor microenvironment while minimizing immune-related side effects in healthy tissues. Additionally, Lyvgen offers services related to tumor immune agonistic antibodies, local activation strategies, and synthetic biology engineering, leveraging its cross-linking-dependent antibody platform to enhance therapeutic efficacy in cancer treatment.

Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.

Lachesis is a high-tech company based in Shenzhen, China, specializing in clinical applications that integrate information and communications technology with internet technology. The company develops intelligent products and services aimed at enhancing the efficiency of healthcare delivery for doctors, nurses, patients, and hospitals. Its offerings include a bedside nursing solution, an interactive smart ward solution, and an IoT platform, all designed to improve management efficiency and accuracy in medical assessments. By providing mobile medical intelligent hardware and application software, Lachesis aims to advance mobile nursing and intelligent medical practices within healthcare institutions.

CF PharmTech, Inc. is a specialty pharmaceutical company based in Suzhou, China, focused on the development and manufacturing of inhalation products for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. Founded in 2007, the company offers a range of products including metered dose inhalers, dry powder inhalers, nasal sprays, and nebulizers. In addition to its product offerings, CF PharmTech provides contract manufacturing organization (CMO) services and is actively involved in research and development in its specialized field. The company aims to provide high-quality and affordable medicines to enhance patient care and management of respiratory conditions, catering to a global market. Its headquarters are strategically located in the Caohu District, ensuring convenient transportation access to major cities like Shanghai and Beijing.

Elpiscience Biopharmaceuticals Co., Ltd. is a clinical-stage immunology company based in Pudong, China, with an additional office in Suzhou. The company specializes in developing next-generation immunotherapies for cancer treatment, focusing on a diverse pipeline of innovative molecules that target various areas within immuno-oncology. Founded by experienced leaders and scientists in the biopharmaceutical industry, Elpiscience aims to advance at least one new therapeutic candidate into clinical trials each year, striving to enhance treatment options for cancer patients globally.

Yao123.com is an online platform that specializes in selling pharmaceutical products. Founded in 2015 and headquartered in Shanghai, China, the company operates as a subsidiary of Sinopharm Group Co. Ltd. Yao123.com employs an integrated online-offline business model, allowing customers to access a wide range of medical and healthcare products conveniently. The platform aims to enhance the accessibility of pharmaceutical goods, catering to the needs of consumers in a rapidly evolving healthcare landscape.

Sinopharm Online has a pharmaceutical retail platform to provide users with online medication consultation, medical and health management consulting services, etc. The main sales cover Chinese and Western medicines and health products. , medical equipment, Chinese medicine

Hotgen is a biotechnology company based in Beijing that specializes in the research, development, and manufacturing of innovative in-vitro diagnostic products, point-of-care testing solutions, and public safety inspection products. The company focuses on advancing liquid biopsy technology for early cancer screening and has established a multi-omics diagnostic platform that incorporates various biomolecular markers, including proteins, sugar chain exosomes, and DNA methylation. Furthermore, Hotgen's technological framework supports the deployment of diverse biopharmaceuticals such as antibody drugs, live bacteria drugs, and exosome-based therapies. Through its comprehensive development strategy, Hotgen aims to integrate the entire industry chain, facilitating advancements from diagnosis to treatment in the healthcare sector.

Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.

Jianke is anonline B2C pharmacy and healthcare services platform.

Lachesis is a high-tech company based in Shenzhen, China, specializing in clinical applications that integrate information and communications technology with internet technology. The company develops intelligent products and services aimed at enhancing the efficiency of healthcare delivery for doctors, nurses, patients, and hospitals. Its offerings include a bedside nursing solution, an interactive smart ward solution, and an IoT platform, all designed to improve management efficiency and accuracy in medical assessments. By providing mobile medical intelligent hardware and application software, Lachesis aims to advance mobile nursing and intelligent medical practices within healthcare institutions.

Teligene Ltd. is a pharmaceutical research and development company based in Jiangsu, China, established in 2011. The company specializes in the development of small-molecule drugs, particularly innovative treatments for oncology. Teligene's focus is on the research, development, and industrialization of small molecule targeted anti-tumor drugs, utilizing advanced drug development technologies. The experienced management team is well-versed in contemporary trends and practices in drug development both domestically and internationally. Teligene aims to create original anti-tumor drugs with independent intellectual property rights, addressing emerging areas of research and development in the pharmaceutical field.

Founded in 2011, 7LeKang operates nine offline stores and an online pharmacy platform

Innovative Cellular Therapeutics Co., Ltd. is a biotechnology company based in Shanghai, China, focused on the research and development of cell therapy. Established in 2009, the company specializes in creating chimeric antigen receptor T (CAR-T) products aimed at treating blood cancers and solid tumors. Its portfolio includes an allogeneic CAR-T development program utilizing gene editing and gene therapy techniques. The company is dedicated to developing cellular immunotherapies for late-stage solid tumors, including colorectal and thyroid cancers, with the goal of improving patient outcomes and enhancing quality of life for those affected by cancer.

Jabrehoo focusing on clinical transformation and innovative research and development of related products in the field of assisted reproduction, genetics and eugenics, providing one-stop solutions for reproductive genetics for assisted reproduction couples, infertile patients, and people who are preparing for pregnancy, and promoting the localization of various detections.

Singlera Genomics Inc. specializes in genetic testing and molecular diagnostic technologies, focusing on non-invasive solutions for cancer screening and diagnosis. The company has developed a methylation detection platform that aids in early tumor detection and cancer prevention. Its offerings include tumor diagnosis, personalized treatment options, non-invasive prenatal diagnosis, and pre-implantation genetic screening, along with customized scientific research services. Founded in 2014 and based in La Jolla, California, Singlera also operates research and development centers in Shanghai, China, and is committed to advancing precision medicine to provide patients with early, accurate, and informative diagnoses.

CF PharmTech, Inc. is a specialty pharmaceutical company based in Suzhou, China, focused on the development and manufacturing of inhalation products for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. Founded in 2007, the company offers a range of products including metered dose inhalers, dry powder inhalers, nasal sprays, and nebulizers. In addition to its product offerings, CF PharmTech provides contract manufacturing organization (CMO) services and is actively involved in research and development in its specialized field. The company aims to provide high-quality and affordable medicines to enhance patient care and management of respiratory conditions, catering to a global market. Its headquarters are strategically located in the Caohu District, ensuring convenient transportation access to major cities like Shanghai and Beijing.

Yunshan Medical is a private healthcare management company based in Shenzhen, China. It operates as a comprehensive healthcare service platform that combines authoritative medical expertise with accessible patient services. The firm specializes in high-quality disease diagnosis and treatment, medical-grade physical examinations, tumor screening, and health management solutions. Additionally, Yunshan Medical provides online customized medical services through a mobile application, enabling patients to make reservations, purchase medications, and receive medical advice conveniently. This integration of services aims to enhance healthcare access and promote overall health and wellness for its users.

Shanghai Henlius Biotech, Inc. is a biopharmaceutical company based in Shanghai, China, specializing in the research, development, production, and commercialization of biologics, particularly monoclonal antibody (mAb) biosimilars and novel therapies. Founded in 2010, the company focuses on oncology and autoimmune diseases, offering products such as HLX01, a biosimilar for treating non-Hodgkin lymphoma. Henlius is actively advancing its pipeline, with multiple products under review for regulatory approval, alongside conducting numerous clinical studies for various therapies. The company collaborates with partners, including agreements to develop treatments for COVID-19 and eye diseases. Shanghai Henlius Biotech is a joint venture between Shanghai Fosun Pharmaceutical and Henlius Biopharmaceuticals, established in 2009, and operates out of the Shanghai Caohejing High-Technology Park.

Annoroad Gene Technology, established in 2012 and headquartered in Beijing, is a prominent player in China's genomics sector, known primarily for its Non-Invasive Prenatal Testing (NIPT) services and advanced genomic research capabilities. The company specializes in next-generation sequencing (NGS) technologies applied to human health and life science research. Annoroad has received multiple accolades, including recognition as a national high-tech enterprise and a pilot organization for high-throughput sequencing clinical applications. It boasts a comprehensive product portfolio that includes the NextSeq 550AR sequencer and various genomic testing reagents, supporting diagnostic applications in human reproduction, oncology, and rare diseases. Additionally, Annoroad has developed SolarGenomics, a cloud-based platform for genomic big data services, and has established robust research and development capabilities, reinforced by a skilled workforce. The company's extensive service offerings span the entire genomics industry chain, enhancing its reputation and fostering partnerships within the sector.

Wellem is an operator of pediatric clinic franchise. United Wellness Pediatric Gubei Clinic (Wellem) is a private clinic that provides care for babies, children, and young adults. They believe in leveraging competition and innovation to create better care, and base their service on the American service standard. They offer general pediatrics, pediatric dental care, specialized childcare, and imported vaccines. And can help children with any issue from physical growth, to nutrition, and language to vision, and even academic skills. Parents can also bring their children for preventative check ups, with little waiting time and simple registration.

Anhui Ligoo New Energy Technology Co., Ltd. is a private company based in Hefei, China, established in 2010. The firm specializes in the research, development, production, and sales of electronic control systems for new energy vehicles. Ligoo manufactures various components, including battery management systems, battery packs, electric drive systems, and charging equipment. The company aims to enhance the functionality and reliability of new energy vehicles, contributing to the broader goal of transforming China into an automotive technology leader. By focusing on innovative solutions, Ligoo seeks to support the global shift towards sustainable transportation and empower millions of households with advanced automotive technologies.

Akeso Biopharma, based in Zhongshan, China, operates as a contract research organization (CRO) specializing in the discovery and development of antibody and protein drugs. Founded in 2012, the company provides comprehensive CRO services to both domestic and international pharmaceutical clients, focusing on areas such as protein expression, antibody generation, assay development, and humanization. Akeso has developed an extensive biopharmaceutical research and development platform, with a robust product pipeline that includes over 30 drugs targeting cancers, autoimmune diseases, inflammation, and cardiovascular conditions. Among these, 17 drugs have progressed to clinical stages, including two first-in-class bi-specific antibody drugs. The company collaborates with various pharmaceutical firms to innovate and develop new drug candidates, establishing itself as a leader in the industry through its advanced facilities and expertise.

Sansure Biotech Inc. is a biotechnology company based in Changsha, Hunan Province, established in 2008. The company specializes in molecular diagnosis and genetic testing, developing and manufacturing a range of products that include nucleic acid extraction kits, real-time polymerase chain reaction (PCR) diagnostic kits, and fluorescence systems. Its product portfolio encompasses diagnostic kits for various health concerns, including novel coronavirus detection, viral hepatitis, AIDS, cancer biomarkers, and respiratory, digestive, and genetic diseases. Additionally, Sansure Biotech provides instruments and consumables to support its diagnostic offerings. The company primarily serves hospitals and laboratories both in China and internationally, focusing on enhancing diagnostic capabilities across multiple medical fields.

USCI Medical Laboratory is a national high-tech company specializing in genetic testing services, particularly in tumor diagnosis and eugenics gene sequencing. The laboratory focuses on developing integrated diagnostic equipment and clinical processes that enhance bioinformatics and minimize diagnostic errors. Its capabilities include batch sample detection, mass data analysis, and advanced gene sequencing technologies. USCI Medical Laboratory is committed to providing comprehensive medical health solutions that encompass disease prevention, prediction, detection, interpretation, and intervention, thereby advancing the field of genomic disease screening and prevention.

Anbiping is a number of reagents and supporting devices have indeed been independently created by Anbiping, which focuses on tumour screening and correct diagnosis. Pathology is the main application department. It has been established that product lines for liquid-based cytology, polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization can be used to screen for and diagnose tumors based on everything from cell morphology to protein expression.

Righton is a Shanghai-based biotechnology company specializing in genetic engineering and the development of in vitro diagnostic products. The company focuses on researching and producing molecular diagnostic reagent kits, offering comprehensive scientific research and testing services. Righton aims to advance the field of molecular diagnostics through innovative solutions that enhance medical testing and diagnostics capabilities.

Huayin Health Group is a medical research laboratory based in Guangzhou, China, established in 2009. The company specializes in clinical medical testing and pathological diagnosis, offering services that include disease detection for conditions like Thalassaemia, chromosomal genetic disease diagnosis, and high-throughput sequencing. Additionally, Huayin Health provides remote diagnosis and clinical research services, as well as health management and public health testing. By focusing on comprehensive healthcare solutions, the company aims to enable patients to access professional medical services efficiently.

Liferiver is a PCR-based molecular diagnostic solution provider, developing, manufacturing, and marketing real-time PCR diagnostic kits as well as instruments. They offer over 400 testing kits covering most infectious diseases, genetic diseases, tumors, organ transplants, and others. Their kits are compatible with most real-time PCR systems of various brands including ABI, Bio-Rad, and Roche.

Kangnuo Pharmaceutical offers biopharmaceutical enterprise integrating R&D, production and sales. They develops, produces, and sells NAD series products.

Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP Biopharma. It also is developing two clinical stage drug candidates: MIL60, a biosimilar to Genentech's Avastin, and MIL62, a proposed treatment for chronic lymphocytic leukemia.

ARSMO Plastic Aesthetic Hospital Holding Co., Ltd. is a medical facility based in Nanjing, China, specializing in plastic surgery, cosmetic dermatology, and dental services. Established in 2010, the hospital was initially known as SINO-KOR Plastic and Aesthetic Hospital Investment Co., Ltd. until it rebranded in January 2015. The hospital focuses on providing a range of aesthetic medical procedures, catering to the growing demand for cosmetic enhancements and dental care in the region.

Royal Bio-Pharmaceutical specializes in the development and production of biopharmaceuticals, focusing on both therapeutic and preventive products. The company is engaged in creating vaccines and biological reagents that aim to address various health needs. Through its innovative approach, Royal Bio-Pharmaceutical contributes to advancements in the field of medicine by providing solutions that enhance patient care and disease prevention.

ASK e-Health is a developer of a health management service platform specifically designed for outpatients with chronic illnesses. Its mobile application system simplifies the integration of medical services, allowing developers to create health-oriented applications without the need for extensive coding. The platform offers a range of services, including online consultations, diagnosis, data monitoring, and follow-up treatment, enabling patients to effectively track their health. By focusing on chronic illness management, ASK e-Health aims to improve patient outcomes and reduce recurrence rates, thereby enhancing the overall efficiency of healthcare delivery for individuals managing ongoing health conditions.

Danxia has the capacity to produce integrated machines. They offer forms of assistance to domestic producers while offering their clients premium products, technical assistance services.

Biovalley manufactures and sells the breviscapine series of drugs. They provide injections, capsules, tablets, dripping pills, erigeron capsules, and soft capsules. They provide solutions for ischemic cardiovascular and cerebrovascular diseases, stroke sequelae, and coronary heart disease treatment.

Vivachek is a manufacturer based in Hangzhou, China, specializing in high-quality blood glucose meters and related health monitoring devices. The company offers a range of products, including micro-pension blood glucose meters, glucose meter systems, blood pressure monitors, digital thermometers, lancets, and immunofluorescence products. These devices are designed to help users monitor their blood glucose levels and overall health, promoting healthier lifestyles. Vivachek operates a production facility that adheres to rigorous quality standards, including China GMP, ISO, and FDA QSR guidelines, ensuring the reliability and safety of its products in the global market.

Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP Biopharma. It also is developing two clinical stage drug candidates: MIL60, a biosimilar to Genentech's Avastin, and MIL62, a proposed treatment for chronic lymphocytic leukemia.

Vanguarj produces pharmaceutical medicine. They provide research and development, production, and sales of chemical medicines and Chinese patent medicines, external drug process research and development, production technology services, and external technology transfer.

HH Medical Diagnostics is a clinical mass spectrometry testing technology platform. They provide testing items such as accurate measurement and determination of serum vitamins, quantitative testing of amino acids and organic acids, bioequivalence, and pharmacokinetics.

Bioscience provides in vitro diagnostic medical devices and reagents intended to enhance the diagnostic capabilities of healthcare professionals. They offer products that include chemiluminescence, point-of-care testing, and supporting instruments and reagents that enable healthcare organizations to offer enhanced care.

Bioscience provides in vitro diagnostic medical devices and reagents intended to enhance the diagnostic capabilities of healthcare professionals. They offer products that include chemiluminescence, point-of-care testing, and supporting instruments and reagents that enable healthcare organizations to offer enhanced care.

Xuele Zhongguo is an online learning platform for children of primary school.

Anda Exhibition provides hall designs, construction, and operations services. They plan for exhibition halls such as museums and themed exhibition halls and offer integrated services for exhibition arrangements.

Xueleyun is an educational ecosystem platform that uses Internet technology and big data application technology to serve the education management departments, schools, teachers, students, parents, third-party partners and other seven groups.

Ximalaya Xinxi Keji is a domestic manufacturer of 3D printing equipment and a comprehensive solution provider.

Supoin specializes in providing comprehensive IoT data solutions aimed at enhancing the connectivity and communication between people, objects, and environments. The company focuses on developing and manufacturing automatic bar code identification devices, which play a crucial role in the logistics, retail, and healthcare sectors. These devices facilitate the identification and storage of data for a diverse range of products, addressing the needs for asset management, personnel supervision, and safety monitoring. By leveraging IoT technology, Supoin strives to deliver real-time, dynamic, and accurate data collection and management solutions.

Shenzhen Qiche Wang is a professional automotive Car networking system and product developer.

Zhongding Technology is a solution provider for intelligent logistics. They also offer technical solutions for traditional logistics.

Herun Media Group is a media company based in Beijing, China, founded in 2007. The organization specializes in advertising across various platforms, including film, television, internet, mobile (3G), and outdoor media. By leveraging multiple channels, Herun Media Group aims to deliver comprehensive advertising solutions to its clients, adapting to the evolving landscape of media consumption.

Anhui Ligoo New Energy Technology Co., Ltd. is a private company based in Hefei, China, established in 2010. The firm specializes in the research, development, production, and sales of electronic control systems for new energy vehicles. Ligoo manufactures various components, including battery management systems, battery packs, electric drive systems, and charging equipment. The company aims to enhance the functionality and reliability of new energy vehicles, contributing to the broader goal of transforming China into an automotive technology leader. By focusing on innovative solutions, Ligoo seeks to support the global shift towards sustainable transportation and empower millions of households with advanced automotive technologies.

Boya Bio-pharmaceutical Group Co., Ltd., formerly Jiangxi Boya Bio-pharmaceutical Co., Ltd, is a China-based company principally engaged in the research, development, production and distribution of blood products.

Chamlion 3D is a national high-tech enterprise incubated and established by the Additive Manufacturing Institute of Nanjing University of Aeronautics and Astronautics. Digital solutions for dental 3D printing, leading the digital transformation and upgrading of the industry. Chenglian Technology is deeply engaged in the field of dentistry, with its in-depth understanding of the industry and rich product development.